Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,132
Closed -$9.12K 4153
2026
Q1
$9.12K Sell
1,132
-76
-6% -$889 ﹤0.01% 3708
2025
Q4
$34.3K Buy
1,208
+820
+211% +$32.1K ﹤0.01% 2929
2025
Q3
$13.3K Buy
+388
New +$8.96K ﹤0.01% 2399
2024
Q4
Sell
-3,099
Closed -$273K 2297
2024
Q3
$273K Buy
3,099
+207
+7% +$17.4K 0.02% 1254
2024
Q2
$198K Sell
2,892
-395
-12% -$47K 0.02% 1246
2024
Q1
$565K Buy
+3,287
New +$408K 0.08% 421
2023
Q4
Sell
-740
Closed -$62.9K 1602
2023
Q3
$62.9K Sell
740
-1,470
-67% -$187K 0.01% 1249
2023
Q2
$332K Buy
+2,210
New +$380K 0.06% 644
2022
Q3
Sell
-745
Closed -$106K 1104
2022
Q2
$106K Buy
745
+382
+105% +$60.8K 0.04% 628
2022
Q1
$91K Buy
+363
New +$152K 0.04% 527

Other funds holding BCAB

XTX Topco's BCAB Position: Q2 2026 in Review

XTX Topco sold out of BIOATLA INC (BCAB) in Q2 2026, closing a stake of 1,132 shares — an estimated $9.12K sold.

XTX Topco first reported a position in BCAB in Q1 2022 and held it in 10 quarters. The position peaked at $565K in Q1 2024. 21 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

  • XTX Topco reported no remaining BIOATLA INC position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 1,132 BIOATLA INC shares in Q2 2026, an estimated $9.12K.
  • XTX Topco first reported a position in BIOATLA INC in Q1 2022 and held it in 10 quarters.
  • XTX Topco's BIOATLA INC position peaked at $565K in Q1 2024.
  • 21 funds tracked by Wall St. Rank held BIOATLA INC as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.